249 related articles for article (PubMed ID: 11158329)
21. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
22. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
23. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1.
Chaudhry AZ; Vitullo AD; Gronostajski RM
J Biol Chem; 1999 Mar; 274(11):7072-81. PubMed ID: 10066764
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
26. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
[TBL] [Abstract][Full Text] [Related]
27. Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2.
Lee SK; Na SY; Jung SY; Choi JE; Jhun BH; Cheong J; Meltzer PS; Lee YC; Lee JW
Mol Endocrinol; 2000 Jun; 14(6):915-25. PubMed ID: 10847592
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells.
Tsitoura DC; Rothman PB
J Clin Invest; 2004 Feb; 113(4):619-27. PubMed ID: 14966571
[TBL] [Abstract][Full Text] [Related]
29. Chronic antagonism of nuclear factor-kappaB activity in cytotrophoblasts by dexamethasone: a potential mechanism for antiinflammatory action of glucocorticoids in human placenta.
Rosen T; Krikun G; Ma Y; Wang EY; Lockwood CJ; Guller S
J Clin Endocrinol Metab; 1998 Oct; 83(10):3647-52. PubMed ID: 9768679
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ.
Mittelstadt PR; Ashwell JD
J Biol Chem; 2001 Aug; 276(31):29603-10. PubMed ID: 11397794
[TBL] [Abstract][Full Text] [Related]
31. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
32. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene.
Waltner-Law M; Daniels MC; Sutherland C; Granner DK
J Biol Chem; 2000 Oct; 275(41):31847-56. PubMed ID: 10913132
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of p300-mediated transcription by the kinase MEKK1.
See RH; Calvo D; Shi Y; Kawa H; Luke MP; Yuan Z; Shi Y
J Biol Chem; 2001 May; 276(19):16310-7. PubMed ID: 11278389
[TBL] [Abstract][Full Text] [Related]
35. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
36. Prednisone inhibits the IL-1β-induced expression of COX-2 in HEI-OC1 murine auditory cells through the inhibition of ERK-1/2, JNK-1 and AP-1 activity.
Hong H; Jang BC
Int J Mol Med; 2014 Dec; 34(6):1640-6. PubMed ID: 25319133
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
[TBL] [Abstract][Full Text] [Related]
38. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment.
Jee YK; Gilmour J; Kelly A; Bowen H; Richards D; Soh C; Smith P; Hawrylowicz C; Cousins D; Lee T; Lavender P
J Biol Chem; 2005 Jun; 280(24):23243-50. PubMed ID: 15826950
[TBL] [Abstract][Full Text] [Related]
39. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
[TBL] [Abstract][Full Text] [Related]
40. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells.
Adcock IM; Brown CR; Gelder CM; Shirasaki H; Peters MJ; Barnes PJ
Am J Physiol; 1995 Feb; 268(2 Pt 1):C331-8. PubMed ID: 7864072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
